Literature DB >> 8655643

Protein kinases in the control of mitosis: focus on nucleocytoplasmic trafficking.

P Gallant1, A M Fry, E A Nigg.   

Abstract

The eukaryotic cell nucleus is a highly dynamic organelle. This is illustrated most dramatically during mitosis, when the nuclear envelope breaks down, the nuclear lamina disassembles, chromosomes condense, and a microtubule-based spindle apparatus distributes sister chromatids to the dividing daughter cells. Many of these dramatic changes in nuclear architecture and microtubule organization are controlled by phosphorylation and dephosphorylation events. Whereas the cardinal role of cyclin-dependent kinases (CDKs) in the regulation of mitosis is well established, there is now clear evidence for the requirement of additional mitotic protein kinases. Studies into the regulation of CDKs and other mitotic kinases have revealed that these enzymes undergo cell cycle dependent changes in subcellular distribution, suggesting that localization may contribute to regulating their activities. This article describes some recent findings relating to the nucleocytoplasmic translocation of CDK/cyclin complexes at the onset of mitosis. In addition, it summarizes recent information on two novel human protein kinases which have been implicated in the control of mitotic progression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8655643     DOI: 10.1242/jcs.1995.supplement_19.3

Source DB:  PubMed          Journal:  J Cell Sci Suppl        ISSN: 0269-3518


  12 in total

1.  Nuclear export of cyclin B1 and its possible role in the DNA damage-induced G2 checkpoint.

Authors:  F Toyoshima; T Moriguchi; A Wada; M Fukuda; E Nishida
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

Review 2.  CAS, the human homologue of the yeast chromosome-segregation gene CSE1, in proliferation, apoptosis, and cancer.

Authors:  U Brinkmann
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

3.  Cyclin A- and cyclin E-Cdk complexes shuttle between the nucleus and the cytoplasm.

Authors:  Mark Jackman; Yumiko Kubota; Nicole den Elzen; Anja Hagting; Jonathon Pines
Journal:  Mol Biol Cell       Date:  2002-03       Impact factor: 4.138

4.  Cell cycle-dependent subcellular localization of the TSG101 protein and mitotic and nuclear abnormalities associated with TSG101 deficiency.

Authors:  W Xie; L Li; S N Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

5.  The cell cycle Cdc25A tyrosine phosphatase is activated in degenerating postmitotic neurons in Alzheimer's disease.

Authors:  X L Ding; J Husseman; A Tomashevski; D Nochlin; L W Jin; I Vincent
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

6.  Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication.

Authors:  A B Niculescu; X Chen; M Smeets; L Hengst; C Prives; S I Reed
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

7.  Molecular cloning and cell-cycle-dependent expression of the acetyl-CoA synthetase gene in Tetrahymena cells.

Authors:  S Wang; S Nakashima; O Numata; K Fujiu; Y Nozawa
Journal:  Biochem J       Date:  1999-10-15       Impact factor: 3.857

8.  Molecular cloning and cell-cycle-dependent expression of a novel NIMA (never-in-mitosis in Aspergillus nidulans)-related protein kinase (TpNrk) in Tetrahymena cells.

Authors:  S Wang; S Nakashima; H Sakai; O Numata; K Fujiu; Y Nozawa
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

9.  Cyclin A2 mutagenesis analysis: a new insight into CDK activation and cellular localization requirements.

Authors:  Nawal Bendris; Bénédicte Lemmers; Jean-Marie Blanchard; Nikola Arsic
Journal:  PLoS One       Date:  2011-07-28       Impact factor: 3.240

10.  Disruption of nucleocytoplasmic trafficking of cyclin D1 and topoisomerase II by sanguinarine.

Authors:  Jon Holy; Genelle Lamont; Edward Perkins
Journal:  BMC Cell Biol       Date:  2006-03-02       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.